A detailed history of Bank Of America Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, Bank Of America Corp holds 321,743 shares of LEGN stock, worth $16.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
321,743
Previous 409,553 21.44%
Holding current value
$16.2 Million
Previous $23 Million 37.97%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$39.5 - $57.22 $3.47 Million - $5.02 Million
-87,810 Reduced 21.44%
321,743 $14.2 Million
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $3.41 Million - $4.34 Million
61,964 Added 17.83%
409,553 $23 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $4.49 Million - $5.47 Million
78,481 Added 29.16%
347,589 $20.9 Million
Q2 2023

Aug 14, 2023

SELL
$46.28 - $75.01 $8.6 Million - $13.9 Million
-185,776 Reduced 40.84%
269,108 $18.6 Million
Q1 2023

May 12, 2023

BUY
$43.42 - $57.37 $9.46 Million - $12.5 Million
217,905 Added 91.95%
454,884 $21.9 Million
Q4 2022

Feb 10, 2023

SELL
$38.8 - $55.46 $6.1 Million - $8.72 Million
-157,226 Reduced 39.88%
236,979 $11.8 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $4.62 Million - $6.92 Million
121,215 Added 44.4%
394,205 $16.1 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $55.0 $435,852 - $714,725
12,995 Added 5.0%
272,990 $15 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $5.05 Million - $7.84 Million
162,642 Added 167.06%
259,995 $9.45 Million
Q4 2021

Feb 08, 2022

BUY
$41.14 - $56.98 $3.83 Million - $5.3 Million
93,071 Added 2173.54%
97,353 $4.54 Million
Q3 2021

Nov 15, 2021

SELL
$35.31 - $50.56 $347,521 - $497,611
-9,842 Reduced 69.68%
4,282 $217,000
Q2 2021

Sep 13, 2021

BUY
$25.8 - $41.09 $364,399 - $580,355
14,124 New
14,124 $579,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.42B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.